Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $25.6200 (-0.08%) ($25.5700 - $26.2500) on Tue. Jun. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.05% (three month average) | RSI | 67 | Latest Price | $25.6200(-0.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.8% a day on average for past five trading days. | Weekly Trend | HALO advances 2.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(48%) IWC(45%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.525% in a week (0% probabilities). VIXM(-32%) UUP(-16%) VXX(-14%) TLT(-3%) IYT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.525% (StdDev 3.05%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $24.55(4.36%) | 10 Day Moving Average | $23.9(7.2%) | 20 Day Moving Average | $23.86(7.38%) | To recent high | -0.1% | To recent low | 57.7% | Market Cap | $3.502b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |